| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |